Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 2 |
2008 | 2 |
2009 | 3 |
2010 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeted therapies in breast cancer: established drugs and recent developments.
Curr Clin Pharmacol. 2008 May;3(2):85-98. doi: 10.2174/157488408784293732.
Curr Clin Pharmacol. 2008.
PMID: 18690883
Review.
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi LH, Sibrowski W, Wülfing P, Kiesel L, Yip GW, Götte M.
Nikolova V, et al. Among authors: fischgrabe j.
Carcinogenesis. 2009 Mar;30(3):397-407. doi: 10.1093/carcin/bgp001. Epub 2009 Jan 6.
Carcinogenesis. 2009.
PMID: 19126645
Item in Clipboard
Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.
Smollich M, Götte M, Kersting C, Fischgräbe J, Kiesel L, Wülfing P.
Smollich M, et al. Among authors: fischgrabe j.
Breast Cancer Res Treat. 2008 Mar;108(2):175-82. doi: 10.1007/s10549-007-9589-5. Epub 2007 Apr 28.
Breast Cancer Res Treat. 2008.
PMID: 17468950
Item in Clipboard
On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
Smollich M, Götte M, Yip GW, Yong ES, Kersting C, Fischgräbe J, Radke I, Kiesel L, Wülfing P.
Smollich M, et al. Among authors: fischgrabe j.
Breast Cancer Res Treat. 2007 Dec;106(3):361-9. doi: 10.1007/s10549-007-9516-9. Epub 2007 Feb 13.
Breast Cancer Res Treat. 2007.
PMID: 17295044
Item in Clipboard
Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
Smollich M, Götte M, Fischgräbe J, Radke I, Kiesel L, Wülfing P.
Smollich M, et al. Among authors: fischgrabe j.
Anticancer Res. 2009 Jun;29(6):2167-71.
Anticancer Res. 2009.
PMID: 19528477
Free article.
Item in Clipboard
Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.
Fischgräbe J, Götte M, Michels K, Kiesel L, Wülfing P.
Fischgräbe J, et al.
Int J Cancer. 2010 Aug 1;127(3):696-706. doi: 10.1002/ijc.25076.
Int J Cancer. 2010.
PMID: 19960438
Free article.
Item in Clipboard
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
Smollich M, Götte M, Fischgräbe J, Macedo LF, Brodie A, Chen S, Radke I, Kiesel L, Wülfing P.
Smollich M, et al. Among authors: fischgrabe j.
Breast Cancer Res Treat. 2010 Sep;123(2):345-57. doi: 10.1007/s10549-009-0644-2. Epub 2009 Nov 27.
Breast Cancer Res Treat. 2010.
PMID: 19943105
Item in Clipboard
Cite
Cite